|
This report is submitted beyond 30-calendar days from allergan¿s receipt due to the exemption transition period.A review of the device history record has been completed.No deviations or non-conformance's noted.Device evaluation: analysis of the returned device identified: brown particles, opening curved on anterior and underweight.A visual and microscopic analysis was performed which identified sharp broken on posterior, striated openings on anterior and radius, creases fold and missing shell.A dimension measurement in the shell was performed which identify the thickness within specification.Base on the device analysis the final assessment is: missing shell due to inconclusive.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: rupture.This is a known potential adverse event addressed in the product labeling.
|